Scott Morris
Co-founder, CEO and CSO at Cirrus Bio- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Cirrus Bio
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Co-founder, CEO and CSO
-
Oct 2021 - Present
-
-
-
International Genomics Consortium
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Scientific Officer
-
May 2014 - Present
-
-
Director, New Technology and Innovation
-
Jun 2010 - May 2014
• Deployed novel Laser Cryo Enrichment (LCE) technology• Created industrial optimization algorithms that doubled productivity• Developed novel methods to perform extraction/quality control of FFPE-derived nucleic acid
-
-
Manager, New Technology and Innovation
-
Jun 2009 - Jun 2010
• Invented and patented the novel LCE technology for robotic laser dissection of frozen specimens• Engineered a novel technology allowing purification of high quality DNA, RNA and miRNA from small tissues.
-
-
Molecular Scientist
-
Jun 2008 - Jun 2009
• Developed multiple molecular extraction and analysis protocols• Developed computational algorithms to analyze microscope slides• Automated substantial portions of IGC's molecular pipeline
-
-
Research Associate
-
Aug 2006 - Jun 2008
• Developed molecular SOPs for a wide range of activities in The Cancer Genome Atlas• Conducted day-to-day processing of samples• Designed and programmed a barcode-based system for tracking biospecimen inventories in PHP/MySQL
-
-
-
Exact Sciences
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Vice President of R&D
-
Mar 2020 - Sep 2021
Employed as result of acquisition to maximize shareholder earn outs Finished projects ahead of schedule and under budget Played a key role in multi-billion dollar acquisitions Employed as result of acquisition to maximize shareholder earn outs Finished projects ahead of schedule and under budget Played a key role in multi-billion dollar acquisitions
-
-
-
-
Co-founder & Chief Scientific Officer
-
May 2014 - Mar 2020
Built flagship PCDx diagnostic Sold to Exact Sciences returning >2X to investors
-
-
Director, New Technologies, Innovation, Research and Development
-
Apr 2012 - Apr 2014
• Served as primary designer of assays and result interpretation• Developed novel methods for targeted next-gen sequencing• Developed algorithms allowing high levels of multiplexing without interference• Developed low-complexity algorithms to analyze next-gen sequencing data that complete in a few seconds
-
-
-
Viomics
-
Phoenix, Arizona Area
-
Co-Founder & Chief Science Officer
-
Nov 2011 - Mar 2020
Developed the LungVantage assay for detection of lung cancer Developed novel machine learning algorithms for bio marker discovery Developed several novel assays to assess quality of blood-derived specimens Sold to Exact sciences returning 75X to investors Developed the LungVantage assay for detection of lung cancer Developed novel machine learning algorithms for bio marker discovery Developed several novel assays to assess quality of blood-derived specimens Sold to Exact sciences returning 75X to investors
-
-
-
University of Illinois Chicago
-
United States
-
Higher Education
-
700 & Above Employee
-
Research Specialist
-
Dec 2005 - Jun 2006
-
-
Education
-
Arizona State University
Master of Business Administration (MBA), Executive MBA -
Arizona State University
Ph.D., Industrial Engineering -
Arizona State University
P.S.M., Computational Biology -
University of Illinois at Chicago
Pharmacology and Toxicology -
University of Florida
Plant Molecular Biology -
Arizona State University
BS, Molecular Biology and Biotechnology